Mega-Deals Or Not, Allergan Transformation Under Way
This article was originally published in The Pink Sheet Daily
Executive Summary
CEO Brent Saunders faces questions about what additional business development the company will pursue with all the cash coming in from the recent sale of its generics business to Teva.